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Summary
A method is described based on high-performance immunoaffinity chromatography for examining
the interactions of immobilized antibodies or related binding agents with their targets. It is shown
how this method can be used to obtain information on the binding, elution and regeneration
kinetics of immobilized binding agents, such as those used with immunoaffinity supports. The
theory behind this approach is briefly described and it is demonstrated how both the kinetic and
thermodynamic properties of a biointeraction can be determined experimentally through this
method. Several applications are used to illustrate this technique, including antibody-antigen
interactions and the binding of aptamers with their targets in the presence of silica-based supports.
The same approach can be adapted for use with other types of targets, binding agents and support
materials.
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1. Introduction
Antibodies have been used for decades as agents for the selective binding of target analytes.
One common application of antibodies has been their use in immunoaffinity
chromatography (IAC) for the purification and isolation of biological compounds. Many
IAC methods have been developed for the isolation of antibodies, hormones, peptides,
enzymes, viruses and other biologically-relevant materials (1-8). The ability of an antibody
to recognize a specific target and bind this target with high affinity has traditionally
provided immunoaffinity methods with good selectivity and low limits of detection.
One important application of antibodies and IAC has been in a technique known as high-
performance immunoaffinity chromatography (HPIAC) (9). HPIAC is a type of IAC that
makes use of immobilized antibodies or antigens on a chromatographic support that can be
used in a flow-based system at reasonably high pressures and flow rates. These properties
make it possible to combine the strong and specific binding of antibodies with the precision,
speed and wide range of detection formats that are possible when using a system designed
for work with high-performance liquid chromatography (HPLC) (6,9-11).
To design methods such as IAC or HPIAC that utilize immobilized antibodies, it is valuable
to have some information on the strength and rates of binding of an antibody to its target, as
*Author for correspondence: Chemistry Department, University of Nebraska, Lincoln, NE 68588-0304 USA. dhage@unlserve.unl.edu.
NIH Public Access
Author Manuscript
Methods. Author manuscript; available in PMC 2013 February 1.
Published in final edited form as:
Methods. 2012 February ; 56(2): 130–135. doi:10.1016/j.ymeth.2011.08.016.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
well as data on dissociation of the antibody-target complex. This information can also be
valuable in the design of solid-phase immunoassays, biosensors, and related techniques. One
approach for obtaining such data is to use surface plasmon resonance (SPR) (12-18).
However, there are some limitations to this technique, especially when its results are to be
used to develop IAC and HPIAC methods. For example, SPR is restricted to materials that
have certain optical properties and this method makes use of a specific detection mode (i.e.,
surface plasmon resonance) which can have moderate detection limits (19). Additional
methods that can be used to obtain information about antigen-antibody binding and other
biointeractions include the enzyme-linked immunosorbent assay (ELISA), kinetic exclusion
assay, or radioimmunoassay. These techniques tend to less expensive than SPR and can be
employed to examine antibody-antigen interactions on either a solid phase or in solution;
however, these approaches are usually manual methods with moderate precision and still
require specific modes of detection (20,21).
An alternative approach, which will be discussed in this chapter, is to use HPIAC columns
to examine the binding of targets to immobilized antibodies or related binding agents (9).
One advantage of this method is that the same support material is used for the biointeraction
analysis and in the final application of the immobilized antibodies or binding agents. Like
SPR and other current methods, HPIAC and related affinity methods can be used to obtain
both kinetic and thermodynamic data on a biointeraction (11,20-26). However, HPIAC is
not limited to a particular detection mode but can be used with a wide variety of detection
schemes, including absorbance, fluorescence, and mass spectrometry (11,25).
The theory of this chromatographic approach for biointeraction studies will be briefly
discussed and the experimental use of this method will be described and illustrated through
several examples. Some examples that will be presented will include the use of this method
to examine the binding of immobilized antibodies against the herbicides 2,4-
dichlorophenoxyacetic acid (2,4-D) or atrazine and against the hormone L-thyroxine
(9,27-29). The extension of this method to other systems will also be considered, such as its
use in studying the binding of L-thyroxine with anti-thyroxine aptamers (9,27-29). It will be
shown how this approach can be used to obtain the association equilibrium constants and
binding capacities for immobilized antibodies or aptamers against a given target, as well as
the association and dissociation rate constants for these interactions under sample
application conditions. The use of this method to examine the dissociation rates of bound
targets under a given set of elution conditions will be demonstrated as well, along with the
utilization of this approach to estimate the regeneration rate of an immobilized binding
agent.
2. Materials
All aqueous solutions and running buffers should be prepared using deionized water, as was
obtained in the following examples by using a NANOpure water purification system
(Barnstead, Dubuque, IA, USA).
2.1. Binding Agents and Targets
The following methods can be used for a variety of antibodies, antigens, and related binding
agents. The specific binding agents and targets that will be used as examples in this chapter
are as follows.
1. The work with 2,4-D and the anti-2,4-D antibodies was carried out using E2/G2
monoclonal anti-2,4-D antibodies that were provided by the Vet Research Center in
Brno (Czech Republic) (29). The 2,4-D; 2,4–chlorophenoxyacetate methyl ester
(2,4-D-Me); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); 2-methyl-4-
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chlorophenoxy acetic acid (MCPA); and 4-chlorophenoxyacetic acid (4-CPA) were
from Sigma-Aldrich (St. Louis, MO, USA).
2. The work with atrazine and its degradation products was carried out using anti-
triazine monoclonal antibodies (cell line AM7B2) produced at the Monoclonal
Antibody Production Facility at the University of California-Berkeley (Berkeley,
CA, USA). The atrazine, deethylatrazine and deisopropylatrazine were supplied by
Ciba-Geigy (Greensboro, NC, USA). Hydroxyatrazine was obtained from Dr.
James D. Carr at the University of Nebraska (Lincoln, NE, USA) (31).
3. In the work using L-thyroxine and anti-thyroxine antibodies, the monoclonal L-
thyroxine antibodies (clone 16A) and L-thyroxine were purchased from Sigma-
Aldrich. The thyroxine aptamers (5′-CGG TCA GGC TTC CG-3′, 5′-/5amMC6/
TCA GGC TTC CG-3′, and 5′-/5Bio/CGG TCA GGC TTC CG-3′) were purchased
and synthesized from Integrated DNA Technologies (Coralville, IA, USA)
(9,27-29).
2.2. Support Materials and Columns
1. A variety of supports and immobilization schemes can also be used with the
described method. The examples given in this chapter were all conducted using
Nucleosil Si-1000-7 silica (7 μm particle size, 1000 Å pore size) or Nucleosil
Si-300-7 silica (7 μm particle size, 300 Å pore size) from P.J. Cobert (St. Louis,
MO, USA).
2. In the examples that are provided in this chapter, the silica support was first
converted into a diol-bonded form, according to a previously-reported method (see
Note 1) (32). The antibodies, or desired binding agent with an amine terminal
linker, were then immobilized onto the diol-bonded support by the Schiff base
method (see Note 2) (33). Alternatively, the binding agent could be biotinylated
and attached through biospecific adsorption to a support that contains immobilized
streptavidin (e.g., as prepared by the Schiff base method) (9,27-29). In each case, a
separate control support should be prepared from the same initial starting material
but without the addition of any binding agent in the immobilization step.
3. Once packed, the support containing the immobilized antibodies or desired binding
agent was typically packed into a 1 cm × 2.1 mm i.d. stainless steel column. This
can be carried out by using a standard downward slurry-packing method. An
alternative approach is to use a method for preparing sandwich microcolumns (see
Note 3) (34). When working with silica, either approach would generally be carried
out using a packing pressure of approximately 3000 psi and a neutral buffer as the
packing solution (e.g., a pH 7.0-7.4 phosphate buffer). A column of equal length
and diameter should also be packed by the same method but instead the column
will contain a control support that is absent of any immobilized binding agent (see
Note 3).
2.3. Apparatus
Many standard HPLC systems can be adapted for the types of measurements that are
described in this chapter.
1. An example of an HPLC system that can be used with this method, and which was
used for the work with the anti-thyroxine antibodies, was as follows. This system
consisted of three Waters 590 pumps (Milford, MA, USA), two Rheodyne Labpro
valves (Rohnert Park, CA, USA), and a Jasco UV-975 UV/Vis detector (Easton,
MD, USA). Data acquisition was performed using an SCB-68 NI shielded interface
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and 16E series PCMCIA card from National Instruments (Austin, TX, USA). Data
were collected using a Gateway Solo 2500 laptop computer (Poway, CA, USA) and
analyzed with a spreadsheet prepared using Microsoft Excel (Microsoft, Redmond,
WA, USA). A circulating water bath and column jacket can be added to this system
for temperature control.
3. Methods
3.1. General Model
1. The scheme in Fig. 1 shows how interactions between an applied target and an
immobilized binding agent such as an antibody are described in this
chromatographic approach. This model is based on the on/off elution scheme that is
typically used in IAC, HPIAC and other types of affinity chromatography (35,36).
An example of a chromatogram that is obtained for this type of analysis is provided
in Fig. 2.
2. The first step in Figs. 1 and 2 involves the application of the target analyte (A) to
the immobilized binding agent or ligand (L). During this step, A is allowed to bind
to L while other non-retained sample components are washed away in the presence
of an appropriate application buffer.
3. The second step in this process involves the dissociation and elution of the bound
target analyte by passing an elution buffer through the support. Antibody-antigen
interactions typically have large association equilibrium constants under the
application conditions that are used in IAC and HPIAC, so a change in the pH or
mobile phase composition is often utilized during the elution step to disrupt this
interaction and cause the target to dissociate from the support (35,36). This type of
non-specific and general step gradient will be the elution mode emphasized in this
report. Alternatively, a competing agent such as an analog of the antigen/target or a
soluble binding agent for the antigen/target can be added to the mobile phase to
produce biospecific elution through competitive binding or displacement of the
antigen/target from the column (8,11,21,26).
4. The third step in this scheme is the regeneration step. During this step, the
application buffer is re-applied to the support. This step allows the immobilized
binding agent to return to its initial conformation before the next sample is applied
to the system (35,36). The process is then repeated.
3.2. Determination of the Extent of Target Retention during Sample Application
1. The first step in Figs. 1 and 2 (i.e., the sample application step) can be used with
the method of frontal analysis, or frontal affinity chromatography (FAC), to obtain
information on the interaction strength and number of binding sites for an
immobilized binding agent with a target under the application conditions (see Note
4). In frontal analysis, a known concentration of the analyte [A] is applied to the
column at a known flow rate while the amount of analyte that is leaving the column
is monitored. As the binding sites within the column become saturated with the
analyte, a breakthrough curve will form (see left section of Fig. 2). If a local
equilibrium is present in the column during sample application, the mean position
of this breakthrough curve can be related to the affinity and binding capacity of the
column for the target.
2. If the analyte and ligand follow a model which has single-site binding between
these agents, the frontal analysis data can be examined by utilizing one of the
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following the equivalent expressions in Eqns. (1) and (2), as discussed previously
(see Refs. (11), (21) or (26) for details).
(1)
(2)
In these equations, KA is the association equilibrium constant for the binding of A
to the immobilized ligand, mL,app is the apparent moles of analyte that are required
to reach the mean point of the breakthrough curve at a given concentration of
applied analyte [A], and mL represents the total moles of binding sites in the
column. The value of mL,app is found by using the difference in breakthrough times
for the analyte on the test column versus the control column and using this data
along with the molar concentration of the applied analyte solution and flow rate at
which this solution is passed through the columns (11). Similar expressions to
Eqns. (1)-(2) can be written in terms of the effective concentrations of the
immobilized binding agent in the column instead of the moles of this agent that are
present (11,26). Expanded forms of these relationships can also be written for
systems with multi-site interactions and analyzed through non-linear regression
methods (11). In the case of a system with single-site interactions, Eqn. (1) predicts
that a plot of 1/mLapp versus 1/[A] should give a linear response with a slope equal
to 1/(KAmL) and an intercept that is equal to 1/mL for a system with single-site
binding. Alternatively, a non-linear fit according to Eqn. (2) can be used. Either
type of fit will make it possible to determine both the association equilibrium
constant for the interaction between A and L and the total moles of binding sites in
the column for A (11). Eqns. (1)-(2) are useful for ligands with weak to moderate
affinities but they can also be utilized for higher affinity systems, such as many
types of antibody-antigen interactions (9,11,21,26).
3. Fig. 3 shows a typical set of breakthrough curves and a double reciprocal plot that
was prepared according to Eqn. (1) to analyze the interactions that occurred
between the herbicide atrazine and various degradation products of atrazine with
immobilized anti-atrazine antibodies in an HPIAC column (31). The moderate-to-
weak affinities of some of the degradation products for the immobilized antibodies
made it possible to use the data obtained from Fig. 3 to compare the association
equilibrium constants and binding capacities for each agent on the HPIAC column
(31). Other reports have used this method to examine the binding of L-thyroxine to
anti-thyroxine aptamers and antibodies (28) and the binding of a 2,4-D and related
herbicides to immobilized anti-2,4-D antibodies (9).
3.3. Kinetics of Analyte Retention
1. Another important application for this method is to study the association and
dissociation kinetics of an analyte on an HPIAC column during the application
step. For most supports used in HPIAC, the support is an efficient material with
relatively fast mass transfer from the bulk of the mobile phase solution to the
surface or interior of the support. Under these conditions the rate of capture of the
analyte by an immobilized antibody during the sample application step can often be
modeled by using an adsorption-limited process (11,25). This type of reaction is
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described in Fig. 1 through the use of a second-order adsorption rate constant (kA)
and a first-order dissociation rate constant (kD).
2. One way to examine the association rate of the analyte with an HPIAC column
during sample application is to measure the free fraction f for the analyte that is
non-retained at various flow rates (see Note 5) (9). If adsorption-limited conditions
are present and the rate of analyte dissociation is slow and negligible versus analyte
adsorption (e.g., as occurs during the early stages of frontal analysis), Eqn. (3) can
be used to relate this free fraction to the flow rate (F), association rate constant,
total number of binding sites present in the column, and the amount of applied
analyte (see Ref. (9) for details).
(3)
The term So is equal to the ratio F/(kAmL), and Load A represents the ratio of the
moles of the applied analyte versus the moles of binding sites in the column, where
Load A= (mol A)/mL. The value of Load A can be found by dividing the moles of
applied analyte at any given point in time by the total binding capacity of the
column, such as determined according to frontal analysis (see Section 3.2). The free
fraction f in Eqn. (3) represents the fraction or relative moles of applied analyte that
are not bound to the immobilized ligand. The value of f at a given point in time and
at any value of Load A can be determined through frontal analysis by comparing
the elution profiles for the analyte on a column containing the immobilized ligand
and on an inert control column over the same time period. During this comparison,
the non-retained area and response for the analyte on the column containing the
ligand is divided by the area over the same time period on the control column to
give the free fraction of the analyte on the test column.
3. Fig. 4 shows a typical plot in which Eqn. (3) has been used to examine the
association kinetics of an applied target with immobilized antibodies. This example
is for the binding of 2,4-D to immobilized anti-2,4-D antibodies (9). The same
approach has been used to study the binding of L-thyroxine to anti-thyroxine
aptamers and antibodies (28). In Fig. 4, it was found that there was a good fit
between Eqn. (3) and the early part of the frontal analysis curve during sample
application (i.e., low Load A values, which represent conditions under which
analyte dissociation should be essentially negligible) (9,25). From the value of So
that was obtained from this fit, along with the known values of F and mL (the latter
from the frontal analysis studies), it was possible to estimate the association rate
constant kA for this interaction. By using the value of the KA that has been
determined through frontal analysis (see Section 3.3), it was also possible to then
obtain the dissociation rate constant kD during sample application, as based upon
the relationship KA=kA/kD (9).
3.4. Characterizing Analyte Dissociation Kinetics During Elution
1. The HPIAC method can also be used to study the kinetics involved in the release of
a retained analyte as an elution buffer is passed through the support (see Note 6).
When using a step gradient for elution, this reaction can be described by a first-
order process, as shown in step 2 in Fig. 1 (note: the addition of soluble ligand to
the mobile phase could also again be used for analyte elution). In this reaction, L*,
A*, A-L* represent the ligand, analyte, and analyte-ligand complex in the presence
of the elution buffer. The term kD* is the dissociation rate constant for the complex
A-L* under the elution conditions. During this process it can often be assumed that
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A* is removed rapidly enough from the column to prevent any significant
rebinding with the immobilized ligand.
2. Based on this model, dissociation of the A-L* complex can be described by the
following first-order rate law and integrated rate expression (see Refs. (10), (37) or
(38) for details).
(4)
(5)
In these equations, t is the time allowed for the elution of A, [A*]o is the amount of A* that
is initially present in the system, and [A*] is amount of analyte present at time t. According
to Eqn. (5), a plot of ln[A*] versus t should be linear during the elution step, giving a slope
equal to –kD* (9,10,37-39). If desired, the association equilibrium constant and association
rate constant under the same elution conditions can be determined by frontal analysis, as
described in Sections 3.2 and 3.3. Alternatively, any two of these parameters can be
measured and used to calculate the third factor, as demonstrated in Section 3.3 (9). This set
of information makes it possible to determine how both the affinity and kinetics of analyte-
ligand binding may be altered as the elution conditions are varied (40).
1. Fig. 5 provides an example that utilized these equations and this approach for
examining the dissociation rate constants for 2,4-D and related herbicides from
anti-2,4-D antibodies. It was possible with this method to see how the use of
different elution conditions affected the dissociation rate constant and the
corresponding time needed for analyte elution from the column and to recover a
given fraction of an applied analyte from an immunoaffinity column. In this
particular case, the apparent rate of dissociation approached a constant value at
flow rates above 0.4 ml/min and increased as a lower pH was used for antigen
elution (9). The method has also been utilized to compare various approaches that
can be used for the dissociation and elution of L-thyroxine from anti-thyroxine
aptamers (28).
3.5. Determination of the kinetics of column regeneration
1. The rate of regeneration is another important factor to consider when an
immobilized antibody support is used for multiple samples. This rate can also be
examined by using HPIAC for biointeraction studies (9). Regeneration is described
by the third step and reaction that are shown in Fig. 1. This reaction used a model
for column regeneration that is based on a first-order reaction for the conversion of
the form of the binding agent in its state during the elution step (L*) to the original
fully active form under the application conditions (L). The term kR is the rate
constant for the conversion of L* to L during column regeneration.
2. According to this first-order model, the rate of column regeneration rate can be
described by using Eqns. (6) or (7).
(6)
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(7)
It is assumed in both of these equations that the reverse reaction is negligible (i.e., that L
does not have appreciable conversion to L* in the presence of the application buffer). Eqn.
(6) can be integrated to give the equivalent expressions in Eqns. (8) and (9), in which t is the
time allowed for column regeneration (see Ref. (9) for details).
(8)
(9)
It is possible to use frontal analysis (see Section 3.2) to acquire measurements of mol L* as
a function of regeneration time. A plot can then be made of –ln(mol L*)o versus t, which
should result in a straight line with a slope that is equal to -kR and an intercept that is equal
to ln(mol L*)o.
1. Fig. 6 gives an example for this particular type of analysis, as was used to examine
the regeneration of an immunoaffinity column containing immobilized anti-2,4-D
antibodies. Good agreement with a linear relationship was seen in Fig. 5, as
predicted by Eqn. (9). The slope of this plot made it possible to estimate the rate
constant for column regeneration and to see how the time allowed for regeneration
affected the apparent binding capacity of the column from one application and
elution cycle to the next (9).
4. Notes
1. The typical coverage of diol groups on the Nucleosil Si-1000 supports for the
examples used in this chapter were in the range of 35-55 μmol diol/g silica, as
determined by an iodometric capillary electrophoresis assay (41). The coverage of
diol groups on the Nucleosil Si-300 support was approximately 300 μmol diol/g
silica. These values will vary from one type of support material to the next and are
highly dependent on the nature of the support and its pore size.
2. In the case of the anti-2,4-D antibodies, the Schiff base method was carried out by
using 1 mg antibodies/50 mg silica in a the total reaction volume was 5 mL, with
the immobilization being completed at 4°C for three days. Slightly different
amounts of antibody and support and alternative reaction times can also be used.
3. The following procedure has been used to prepare an anti-thyroxine sandwich
microcolumn with total dimensions of 1 cm × 2.1 mm i.d. (27). First, a layer of
diol-bonded silica with no immobilized antibodies present was packed into the
column until a layer approximately 4 mm thick. This step was followed by the
addition of enough immobilized antibody silica to create a 1 mm support layer
through multiple injections of slurry that contained this support. A final layer of
diol-bonded silica was then packed into the column at 3000 psi until the top of the
column bed had been reached. This approach resulted in a 1 cm long column that
contained a 1 mm layer of an immobilized anti-thyroxine antibody support between
two layers of diol-bonded silica. A control column was prepared in the same
manner using only diol-bonded silica throughout the column.
4. During the frontal analysis experiments, breakthrough curves should be generated
over a wide range of analyte concentrations. The range of concentrations that can
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be used will depend on the solubility of the analyte and its lower limit of detection
on the HPLC system, as described in detail in Ref. (11). Preliminary studies should
also be carried out at using at least two different flow rates to ensure that moles of
applied analyte that are needed to reach the breakthrough point are independent of
flow rate. It is also recommended that each analyte concentration be applied in
duplicate or triplicate. A correction for non-specific binding to the support and for
the void volume of the system can be made by subtracting the results for the control
column from the results for the column containing the immobilized binding agent.
This correction should be made at each concentration of the applied analyte.
5. Measurements of the free fraction during the sample application step can be made
by using the same chromatograms that are obtained during the frontal analysis
experiments that are described in Section 3.2.
6. The analysis of analyte dissociation rates should be carried out at several flow rates
to ensure that mobile phase mass transfer rates are negligible compared to the rate
of analyte dissociation. A correction for the change in background response should
be made by subtracting the results for the control column from the results for the
column containing the immobilized binding agent.
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Figure 1.
General scheme illustration the kinetic processes used in this experiment to model the
binding and elution of an analyte in affinity chromatography. In this model kA and kD are the
association and dissociation rate constants for the analyte–ligand interaction during sample
application, kD* is the first-order dissociation rate constant which describes analyte elution.
The term kR is the first-order rate constant that describes the regeneration of the immobilized
ligand. The asterisk (*) that appears by the ligands during the elution step is used to indicate
that these agents may be present in a denatured or altered state during this stage of the
analysis.
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Figure 2.
Typical chromatogram obtained during a biointeraction study using frontal analysis for
sample application and the on/off elution mode for 2,4-D and a column that contained
immobilized anti-2,4-D antibodies. Adapted with permission from Ref. (9).
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Figure 3.
Frontal analysis results, as plotted according to Eqn. (1), for the application of atrazine (●),
hydroxyatrazine (○), deethylatrazine (□) or deisopropylatrazine (■) onto a column
containing immobilized anti-triazine antibodies. Based on data from Ref. (30).
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Figure 4.
Comparison of experimental results and the best-fit results according to Eqn. (2) for the
application of a 100 ppb solution of 2,4,5-T to an immobilized anti-2,4-D antibody column.
The values of both Load A and f in this plot are unitless, as indicated by the definition of
these terms. Adapted with permission from Ref. (9).
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Figure 5.
Analysis of the dissociation rate of 2,4-D from immobilized anti-2,4-D antibodies at various
flow rates and at pH 2.5. Based on data from Ref. (9).
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Figure 6.
Examination of the regeneration rate for immobilized anti-2,4-D antibodies in going from
pH 2.5, 0.1 M potassium phosphate buffer to pH 7.0, 0.1 M potassium phosphate buffer at a
flow rate of 0.5 mL/min. Reproduced with permission from Ref. (9).
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